ScholarIQanswers from OpenAlex

EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling

PaperCitations, authors & open-access status

EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling is a paper indexed in ScholarIQ from OpenAlex.

How many citations does EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling have?

ScholarIQcitation count

EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling has 77 citations in the OpenAlex counts ScholarIQ stores.

When was EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling published?

ScholarIQyear

EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling has 2021 year in the ScholarIQ index.

What is the open-access status of EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling?

ScholarIQoa status

EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling has gold oa status in the ScholarIQ index.

What is the DOI of EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling?

ScholarIQdoi

The DOI for EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling is on the source record.

What is the PMID of EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling?

ScholarIQpmid

The PMID for EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling is on the source record.

What is the OpenAlex record for EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling?

ScholarIQopenalex

The OpenAlex for EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial